Bioxis
Bioxis Pharmaceuticals is a cutting-edge company specializing in the discovery, development, production, and commercialization of innovative regenerative medical products. Based in Lyon, France, Bioxis focuses on creating next-generation dermal fillers and other aesthetic solutions that help regenerate tissues and improve patient outcomes. Their leading product, MTI-12, is an ultra-pure chitosan tissular inductor designed to enhance tissue regeneration and aesthetic treatments. Bioxis is known for its advanced biomaterials technology, particularly in the development of hyaluronic acid-based dermal fillers under the brand CYTOSIAL. These products are distributed across Europe and Asia through exclusive agreements. The company is supported by major organizations such as Medicen Paris Region, CNRS, and BPI France, ensuring the highest standards of innovation and quality in the aesthetic dermatology field. Bioxis is committed to providing revolutionary solutions that transform the medical aesthetics landscape.